Revolution Medicines, Inc. is 16.2x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($30.65 B vs $1.89 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADMA | RVMD |
|---|---|---|
| Market cap | $1.89 B | $30.65 B |
| US-listed rank | #2130 | #454 |
| Revenue (latest FY) | $510.17M | $0.00 |
| Net income (latest FY) | $146.93M | -$1.13B |
| Net margin | 28.8% | - |
| P/E (trailing FY) | 12.9 | - |
| SEC filings | 988 | 782 |
Revolution Medicines, Inc. is 16.2x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($30.65 B vs $1.89 B).
In their latest fiscal years, ADMA BIOLOGICS, INC. reported $510.17M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: ADMA BIOLOGICS, INC. and Revolution Medicines, Inc., or browse the full rankings.